Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details 2)

v3.24.1.1.u2
Stockholders' Equity (Details 2) - Restricted Stock Units (RSUs) [Member] - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of options outstanding at beginning of period 67,250  
Weighted average exercise price at beginning of period $ 2.25  
Weighted average remaining life (years) at ending of period 2 years 4 months 6 days 2 years 25 days
Aggregate intrinsic value at beginning of period $ 57,842  
Number of options, Granted 0  
Weighted average grant - date fair value price, Granted $ 0  
Aggregate intrinsic value, Granted $ 0  
Number of options, Exercised 0  
Weighted average exercise price, Exercised $ 0  
Aggregate intrinsic value, Exercised $ 0  
Number of options, Forfeited/canceled (11,086)  
Weighted average grant - date fair value price, Forfeited/canceled $ (2.25)  
Aggregate intrinsic value, Forfeited/canceled $ (9,535)  
Number of options outstanding at ending of period 56,164 67,250
Weighted average exercise price at ending of period $ 2.25 $ 2.25
Aggregate intrinsic value at end of period $ 48,307